HLA-DRB1*16
Paola Nicoletti(University of Florence), Ann K. Daly(Newcastle University), Ursula Gundert‐Remy(Charité - Universitätsmedizin Berlin), Matthew R. Nelson(Deerfield (United States)), Yufeng Shen(Columbia University Irving Medical Center), Ingolf Cascorbi(University Hospital Schleswig-Holstein), Ashley Sawle(University of Cambridge), Einar S. Björnsson(University of Iceland), Guruprasad P. Aithal(NIHR Nottingham Digestive Diseases Biomedical Research Unit), Anneke Nina Werk(PharmacoGenetics (China)), Sally A. Coulthard(Newcastle University), Thomas Stammschulte(PharmacoGenetics (China)), Thomas Urban(Duke University), Aris Floratos(Columbia University)
Cited by 81
Related Papers
The support of human genetic evidence for approved drug indications
|Nature Genetics|2015|1.8k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
The Genome of the Sea Urchin <i>Strongylocentrotus purpuratus</i>
|Science|2006|1.2k